JAK1 and COVID-19: La Rosee La Rosee F F Bremer Bremer HC HC Gehrke Gehrke I I The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation Leukemia Leukemia 2020 2020 10.1038/s41375-020-0891-0 10.1038/s41375-020-0891-0 supplied-pmid 32518419?